ArticleCancer communications (London, England)2025

Lipid metabolism reprograming by SREBP1-PCSK9 targeting sensitizes pancreatic cancer to immunochemotherapy.

Mengyi Lao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.